GET THE FACTS: Is the abortion pill truly 'safe'?

Though the abortion industry has frequently claimed that the abortion pill is "safer than" Tylenol and other drugs, these claims have been debunked. Beyond this, other data and information shows that the abortion pill is much riskier for women than the FDA currently claims:

NEW ANALYSIS: Nearly 11% of women suffer ‘serious adverse events’ after taking abortion pill

This Live Action News article from April 2025 discusses the first analysis from the Ethics and Public Policy Center (EPPC), which "asserts that serious adverse events from mifepristone, the first drug in the abortion pill regimen, occur at a rate approximately 22 times higher than the rate reported on the Food and Drug Administration’s (FDA) label for the drug."

In summary, "That analysis... states that nearly 11% of women (10.93%) experience sepsis, infection, hemorrhaging, or other serious or life-threatening adverse events following a mifepristone abortion." 

How Big Abortion avoids responsibility and buries abortion pill complications

Also in April 2025, Live Action News noted:

As Big Abortion offloads its medical responsibility onto women who purchase the abortion pill, those women are expected to function as their own doctor, nurse, and pathologist in so-called “self-managed” mail-order abortions. Additionally, in an apparent deceptive scheme to hide adverse abortion pill outcomes, abortion profiteers also advise women experiencing serious complications to present to the emergency room (ER) and lie about the cause of those complications.

This article points out how secrecy has been prioritized over women's safety by the abortion industry, delves into the eugenic roots of the abortion pill, describes the unsafe, pre-planned "no-test" abortion pill protocol, and uncovers the strategic burial of abortion pill complications.

WARNING: What They Don't Tell You About The Abortion Pill

ANALYSIS: Abortion pill’s failure rate is nearly double what’s listed on FDA label

This Live Action News article from May 2025 discusses an Ethics and Public Policy Center (EPPC) analysis, which states that the "failure rate of mifepristone, the first drug of the abortion pill regimen, is nearly double the failure rate currently listed on the FDA-approved drug label." The article states:

The data pool used for the research is the largest known on the abortion pill. Researchers analyzed the data from an all-payer insurance claims database of 865,727 prescribed mifepristone abortions from 2017 to 2023. In addition to asserting that the rate of “serious adverse events” from the drug is approximately 22 times higher than the rate reported on the FDA label, the analysis also states that mifepristone’s failure rate is double what the FDA label claims.

While the FDA label asserts a 2.6-3.8% failure rate for mifepristone abortions, real-world data shows a failure rate of 5.26%, according to the researchers.

Concerns grow over stability and efficacy of mail-order abortion drugs

Also in May 2025, Live Action News noted that "The lack of oversight and regulation in shipping and delivery could mean thousands of women obtaining the abortion pill by mail are receiving compromised, less effective drugs — potentially increasing the risk of incomplete abortion."

Abortion pill complications buried for decades in abortion industry plot to hide the truth

This May 2025 Live Action News article noted that "the attempt to hide abortion pill-related adverse events from the Food and Drug Administration (FDA) is not new, and has been going on for nearly two decades."

In addition:

Abortion pill prescribers are required to report complications or deaths of which they are aware; however, if they are unaware, then there will be no report. One way to keep complications under wraps is to advise women to bypass the prescriber and present directly to the ER and lie, claiming a natural miscarriage. Live Action News documented how bad actors in the industry instruct women to go to the ER for complications and suggest that ER staff should falsify medical documents to cover up abortion pill complications. This is a coordinated attempt to bury the truth.

Now, information uncovered by Live Action News reveals that this strategy has existed for two decades. This points to the possibility that adverse events data may be highly skewed.

Abortion Pill Press Conference Shares Shocking New Data

FALLOUT: How dumping patients and pushing a lie misled everyone about the abortion pill

This June 2025 Live Action News article details the reasons why safety data on the abortion pill is highly unlikely to be inaccurate and incomplete. The process of deception is summed up as follows:

Abortion pill prescribers offload their patients to ERs, encouraging women to lie if injured→neither prescribers nor ER personnel learn the truth about the adverse events→no one reports those adverse events to the manufacturer→the manufacturer never learns of the adverse events to report to FDA→the FDA stays in the dark about true complications, impacting safeguards.

REPORT: Removing abortion pill's in-person requirement increases adverse event rate

This Live Action News article from March 2026 states that an Ethics and Public Policy Center (EPPC) analysis "suggests that the rate of serious adverse events following the use of the abortion pill (mifepristone) significantly increases when the in-person dispensing requirement is removed." In addition...

The EPPC's analysis revealed:

• The rate of serious adverse events when the abortion pill was dispensed in person was 10.15%. 

• This rate increased to 11.50% when the in-person dispensing requirement was lifted. 

• This is a 1.35 percentage point increase, which is considered statistically significant. 

• It's also far higher than the 0.5% rate of serious adverse events listed on the FDA's mifepristone drug label. 

• The rate at which women were prescribed mifepristone despite having an ectopic pregnancy rose from 0.27% to 0.41%.